인쇄하기
취소

Chong Kun Dang fared well in first half

Published: 2009-08-17 06:59:00
Updated: 2009-08-17 06:59:00
Chong Kung Dang Pharma made a good start in the first half of this year thanks to robust sales of its leading generic products.

The company garnered 12.5 billion won in sales of Salotane (losartan potassium), a generic Cozaar, for the January-June period. Industry watchers predict that this year's sales will easily exceed 20 billion won.

Nevertheless, Chong Kun Dang recorded 25.5 billion ...

Fees

- Email service daily and homepage access.
  1. $300 per month.
  2. 5 Email holders per each company.
  3. Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.